Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
The current price of Johnson & Johnson in the market is 976,6 zł, with a 24-hour trading volume of 5,1B zł. The asset's market cap is 2,35T zł, after moving -0.82% in the last day.
Tokenized Johnson & Johnson is trading at 993,11 zł, with a tokenized market cap of 164,15M zł and a 24-hour trading volume of 3,67M zł. The tokenized asset has moved -0.00% in the past 24 hours.